Literature DB >> 8649825

Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.

A Hongo1, C D'Ambrosio, M Miura, A Morrione, R Baserga.   

Abstract

THe type 1 insulin-like growth factor receptor (IGF-IR) plays an important role in mitogenesis and transformation. It has been previously shown that mitogenic signaling and transforming activity of the IGF-IR can be dissociated: a receptor truncated at residue 1229 (C-terminus) is fully mitogenic, in terms of its response to IGF-I, but cannot transform 3T3-like cells that are devoid of endogenous IGF-IRs (R- cells). We have extended our mutational analysis of the C-terminus of the human IGF-IR, by stably transfecting several mutant receptors into R- cells, and testing the resulting cell lines for IGF-I-mediated mitogenic response and formation of colonies in soft agar. The results indicate that the transforming domain of the IGF-IR can be localized between residues 1245 and 1310, these sequences being not required for mitogenic signaling. Within these residues, there are at least two areas that contribute to the transforming activity of the receptor.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8649825

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  22 in total

1.  Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia.

Authors:  Si Won Lee; Soo Yoon Lee; Sa Ra Lee; Woong Ju; Seung Cheol Kim
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  The insulin-like growth factor I receptor as a physiologically relevant target of p53 in apoptosis caused by interleukin-3 withdrawal.

Authors:  M Prisco; A Hongo; M G Rizzo; A Sacchi; R Baserga
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

Review 3.  The IGF-I receptor and cancer.

Authors:  R Baserga; M Resnicoff; M Dews
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

4.  Requirement for phosphatidylinositol 3-kinase in epidermal growth factor-induced AP-1 transactivation and transformation in JB6 P+ cells.

Authors:  C Huang; W Y Ma; Z Dong
Journal:  Mol Cell Biol       Date:  1996-11       Impact factor: 4.272

5.  14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor.

Authors:  R W Furlanetto; B R Dey; W Lopaczynski; S P Nissley
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

6.  Insulin-like growth factor II stimulates cell proliferation through the insulin receptor.

Authors:  A Morrione; B Valentinis; S Q Xu; G Yumet; A Louvi; A Efstratiadis; R Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

7.  Insulin-like growth factor I receptor signaling in transformation by src oncogenes.

Authors:  B Valentinis; A Morrione; S J Taylor; R Baserga
Journal:  Mol Cell Biol       Date:  1997-07       Impact factor: 4.272

8.  The differential effects of prostate stromal cells derived from different zones on prostate cancer epithelial cells under the action of sex hormones.

Authors:  Qi Jiang; Bang-Min Han; Fu-Jun Zhao; Yan Hong; Shu-Jie Xia
Journal:  Asian J Androl       Date:  2011-07-18       Impact factor: 3.285

9.  IGF-I stimulation of extracellular acidification is not linked to cell proliferation for autocrine cells.

Authors:  R M Robinson; R M Akers; K E Forsten
Journal:  Endocrine       Date:  2001-07       Impact factor: 3.633

10.  IGF-I activates caspases 3/7, 8 and 9 but does not induce cell death in colorectal cancer cells.

Authors:  Shi Yu Yang; Capucine Bolvin; Kevin M Sales; Barry Fuller; Alexander M Seifalian; Marc C Winslet
Journal:  BMC Cancer       Date:  2009-05-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.